Financial information

The information source is the annual report of the company with business id 556571-7039

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 15,176,880 Revenue Up 14,486,820 Revenue Up
Financial expenses: 25,368 Revenue Up 0
Earnings before taxes: 372,455 Revenue Down 577,415 Revenue Up
Total assets: 5,238,312 Revenue Up 3,576,931 Revenue Up
Current assets: 5,175,013 Revenue Up 3,507,768 Revenue Up
Current liabilities: 4,863,646 Revenue Up 2,904,199 Revenue Up
Equity capital: 372,993 Revenue Down 670,924 Revenue Up
Share capital: 10,000 10,000
Number of employees: 227 Revenue Up 204 Revenue Up

Financial ratios

Solvency: 7.1% Revenue Down 18.8% Revenue Down
Turnover per employee: 66,858 Revenue Down 71,014
Profitability: 2.5% Revenue Down 4.0%
Return on equity (ROE): 99.9% Revenue Up 86.1% Revenue Up
Current ratio: 106.4% Revenue Down 120.8% Revenue Down
Return on assets (ROA): 7.6% Revenue Down 16.1% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202412
Number of months: 12
Turnover: 15,176,880
Financial expenses: 25,368
Earnings before taxes: 372,455
Total assets: 5,238,312
Current assets: 5,175,013
Current liabilities: 4,863,646
Equity capital: 372,993
Share capital: 10,000
Number of employees: 227

Financial ratios

Solvency: 7.1%
Turnover per employee: 66,858
Profitability: 2.5%
Return on equity (ROE): 99.9%
Current ratio: 106.4%
Return on assets (ROA): 7.6%